Compulsory licence conditions
- Label products made under compulsory licence and post supply details online
Retained EU Law
2006
United Kingdom
Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems
At a glance
What's here
3 compliance obligations
Who this Act binds
Plus 2 non-business duties on Crown ministers, regulators, local authorities or tribunals — shown collapsed under each section below.
What this Act requires
Sections that create concrete duties on businesses or carry penalties. Procedural and definitional sections are folded into the “Browse other sections” expander at the bottom of each group. Click any section title to read the source text on legislation.gov.uk.
Action by customs authorities
Other duties (1) — Crown / regulator
- Customs authorities must detain suspected illicit pharmaceutical imports and notify all parties Crown / Minister / Government department
Termination or review of the licence
Other duties (1) — Crown / regulator
- Competent authority must review compulsory licence conditions on request Crown / Minister / Government department
Browse 17 other sections — procedural / definitional / commencement
Scope
Definitions
Competent authority
Eligible importing countries
Extension to least-developed and developing countries which are not members of the WTO
Application for a compulsory licence
Rights of the rights-holder
Verification
Prior negotiation
Refusal of the application
Notification
Prohibition of importation
Personal luggage exception
Appeals
Safety and efficacy of medicinal products
Review
Entry into force
Explore more
Browse legislation
Find other UK business legislation with related guidance.